Birgit H. Amann, MD
Associate Medical Director
Rochester Center for Behavioral Medicine
Rochester Hills, Michigan
Kenneth L. Schaecher, MD, FACP
Salt Lake City, Utah
THIS PROGRAM WAS ORIGINALLY RELEASED AS A LIVE AUDIOCONFERENCE SERIES BEGINNING ON SEPTEMBER 10, 2007. IF YOU RECEIVED CME OR CPE CREDIT FOR THE AUDIOCONFERENCE, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE VERSION.
Childhood ADHD is a widely recognized condition, with an estimated 12% of school-aged children being affected. The 2006 addition of the HEDIS ® measure for ADHD Medication Follow-up exemplifies the need for tracking and improving clinical and resource management for the condition. More recently, health care providers and health plan administrators have acknowledged the long-term health care utilization issues related to the persistence of ADHD from childhood through adolescents and into adulthood.
This program is designed to update participants on the more recent developments in the identification, treatment, and management of ADHD in patients of all ages. Faculty present information on the importance of a multidisciplinary approach to management—medical, pharmacotherapy, and behavioral therapy. Further, tools and strategies that promote more cost-effective, high quality, and evidence-based care are presented.
HEDIS ® is a registered trademark of the National Committee for Quality Assurance. All rights reserved.
. Target Audience
Managed Care Medical Directors, Pharmacy Directors, Physicians, and Pharmacists
Upon completion of this educational activity, the participant should be able to:
Describe the socioeconomic burden caused by ADHD across the lifespan.
Evaluate ways to improve adherence and compliance to current ADHD treatment guidelines regarding follow-up visits and monitoring for drug adverse effects.
Discuss how to assess and report the quality of ADHD care as required by the HEDIS measurement set.
Explore ways that managed care organizations can implement quality initiatives for ADHD care.
Birgit H. Amann, MD has received funding for clinical research from Eli Lilly and Company, Shire Pharmaceuticals, McNeil, and Novartis Pharmaceuticals Corporation; and is on speakers’ bureaus for Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Shire Pharmaceuticals, UCB, and McNeil.
Kenneth L. Schaecher, MD, FACP has no financial interests to disclose.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the National Association of Managed Care Physicians (NAMCP) and Medical Communications Media, Inc. The NAMCP is accredited by the ACCME to provide continuing medical education to physicians.
NAMCP designates this continuing medical education activity for a maximum of 1 AMA PRA Category I credit TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Number 221-999-07-080-H01-P has been assigned to this program (initial release date December 1, 2007). This program is approved for 1.0 contact hours (0.10 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Participants must pass the post-test with a score of 70% or higher and complete the program evaluation to receive pharmacy CE credit. No partial credit will be given.
Co-sponsored by the National Committee for Quality Assurance (NCQA)
Commercial Support Statements
Supported by an educational grant from McNeil Pediatrics Division of McNeil-PPC, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC
Please turn off all pop-up blockers.
Click on the “start program” icon. This will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or update/correct existing registration information. When ready, click on the “continue to program” icon at the bottom of the screen. This will take you to a brief pre-program survey.
The next screen will permit you to check for or download the Flash player required to run this program.
Clicking “start the virtual meeting” will allow you to begin the program presentation. This activity will require approximately 60 minutes to complete.
Upon completion of the program, click on the post-test button to access the post-test and program evaluation. This will bring you to a brief post-program survey.
Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 70% on the post-test is required for a CME/CPE statement of credit. Two attempts are allowed.
©2007, Medical Communications Media, Inc. All Rights Reserved.
None of the contents may be reproduced in any form without prior written permission of the publisher. The opinions expressed in this activity are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Managed Care Physicians, NCQA, ProCE, Inc., or McNeil Pediatrics. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and of possible contraindications or risks, and without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.